Suppr超能文献

服用华法林并入住急诊室的患者凝血酶原时间过度延长。

Excessive prolongation of prothrombin time among patients treated with warfarin and admitted to the emergency room.

作者信息

Habib George, Nashashibi Munir, Khateeb Arin, Goichman Sharon, Kogan Asia

机构信息

Department of Medicine, Carmel Medical Center, Faculty of Medicine, Technion, Isreal Institute of Technology, Haifa, Israel.

出版信息

Eur J Intern Med. 2008 Mar;19(2):129-34. doi: 10.1016/j.ejim.2007.08.006.

Abstract

INTRODUCTION

Patients treated with warfarin are uncommonly admitted with excessive prolongation of international normalized ratio (INR) of prothrombin time (PT) to the emergency room (ER). Here we wanted to evaluate the reasons behind this prolongation, clinical and laboratory parameters, course and outcome of these patients.

PATIENTS AND METHODS

Consecutive patients admitted to the ER with prolonged PT-INR>6 under warfarin treatment and who gave sufficient information regarding history of warfarin treatment, were followed prospectively. Patients or care-givers were asked about warfarin treatment, PT monitoring, current and new medications especially antibiotics and diet. Clinical and laboratory parameters, course and outcome were also documented. Age and gender matched patients with therapeutic INR level were used as a control group.

RESULTS

75 patients finished the study. The median INR level among the patients was 8.5 and a range of 6.1-59.5. The median duration of warfarin treatment was 12 months among the patients vs. 36 in the control group, p<0.001 and family physician was the sole decider on warfarin dose in 71 patients vs. 49 in the control group, p<0.100. 19 patients adhered to balanced diet vs. 34 in the control group, p=0.01. Dose increment of warfarin was the most common definite cause of prolonged PT followed by adding new medication especially amiodarone and recently started warfarin. Significantly more patients had evidence of bleeding than the control group but no difference in mean hemoglobin level or number of patients transfused with packed cells. No difference in the number of patients hospitalized or duration of hospitalization, but 5 in-hospital fatalities in the patients' group vs. none in the control group.

CONCLUSION

Excessive PT prolongation is mainly due to warfarin dose increment, adding new medication especially amiodarone and recently started warfarin. It is significantly more associated with bleeding and higher in-hospital mortality.

摘要

引言

服用华法林的患者因凝血酶原时间(PT)的国际标准化比值(INR)过度延长而罕见地被送往急诊室(ER)。在此,我们旨在评估这种延长背后的原因、临床和实验室参数、这些患者的病程及结局。

患者与方法

前瞻性地随访连续因华法林治疗期间PT-INR>6而入住急诊室且能提供足够华法林治疗史信息的患者。向患者或护理人员询问华法林治疗情况、PT监测情况、当前及新用药物,尤其是抗生素和饮食情况。记录临床和实验室参数、病程及结局。年龄和性别匹配的INR水平处于治疗范围的患者作为对照组。

结果

75例患者完成研究。患者的INR中位数为8.5,范围为6.1 - 59.5。患者的华法林治疗中位时长为12个月,而对照组为36个月,p<0.001;71例患者的华法林剂量由家庭医生独自决定,对照组为49例,p<0.100。19例患者坚持均衡饮食,对照组为34例,p = 0.01。华法林剂量增加是PT延长最常见的确切原因,其次是添加新药物,尤其是胺碘酮以及近期开始使用华法林。有出血证据的患者明显多于对照组,但平均血红蛋白水平或接受红细胞输注的患者数量无差异。住院患者数量或住院时长无差异,但患者组有5例院内死亡,对照组无死亡病例。

结论

PT过度延长主要归因于华法林剂量增加、添加新药物,尤其是胺碘酮以及近期开始使用华法林。其与出血显著相关且院内死亡率更高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验